Oral Solid Dose CDMOs

SGS

Brazil

SGS Integrated CDMO Solutions is the contract development and manufacturing division of the global testing and inspection company SGS SA. Established in 2002 with a specialized UK-based CDMO site (MHRA and FDA inspected), SGS provides formulation development, API manufacturing, sterile fill/finish, lyophilization, and analytical services. A new 55,000 sq ft cGMP facility in Hudson, NH expands their North American capabilities across Phase I-III clinical trials and commercial supply.

SIDEFARMA

Portugal

SIDEFARMA is a Portuguese CMO with over 45 years of experience, specialized in the manufacture of small and medium-size batches of solid dosage forms (coated tablets, tablets, capsules), semi-solids (creams, gels, ointments), and liquid pharmaceuticals. The company provides contract manufacturing, contract packaging, and contract development services following European quality standards, while also commercializing its own branded pharmaceutical products.

Siegfried Group

China

Siegfried Group is a leading global CDMO with 150+ years of pharmaceutical and chemical heritage, operating 13 production sites across Switzerland, Germany, Spain, France, Malta, the USA, and China. The company provides integrated services from early-phase API development through commercial-scale drug substance and drug product manufacturing, including exclusive synthesis, generic APIs, controlled substances, HPAPI handling, sterile formulations, and viral vector manufacturing through subsidiary DINAMIQS. In January 2026, Siegfried announced acquisition of additional US-based small molecule drug substance capacity.

Sinoway Industrial Co., Ltd.

China

Sinoway Industrial Co., Ltd., established in 1987 in Xiamen, China, is a pharmaceutical company specializing in custom development, custom manufacturing, and trading of APIs, pharmaceutical intermediates, polypeptides, prostaglandin series, cosmetic raw materials, herbal extracts, health & food supplements, and finished dosage forms (FDF). They provide one-stop CDMO services from R&D to production. With over 30 years of pharmaceutical export experience serving Europe, North America, Middle East, Japan, and Korea, Sinoway positions itself as both a CDMO and trading company.

SmaBio Labs

United States

SmaBio Labs is a USA-based CDMO located in Research Triangle Park, North Carolina, delivering end-to-end drug development solutions from molecule discovery to market launch. They specialize in Chemistry Manufacturing and Control (CMC) services for small molecules, peptides, biologics, and complex APIs. Their capabilities include analytical services (IND/ANDA support, method development and validation, ICH stability testing, HPLC/UPLC, LC-MS, ICP-MS, NMR, XRPD), drug discovery and process development, API manufacturing (kg-scale cGMP), product development (formulation for oral solid dose, injectables, lyophilized products), and clinical trial material manufacturing (Phase I-III). FDA registered for analytical services. They support HPAPI compounds up to OEB 5.

Special Product’s Line – CDMO Services

Italy

Special Product's Line (SPL) is an Italian CDMO founded in 1978, specializing in the production of non-sterile pharmaceutical products. The company operates a 50,000 sqm state-of-the-art facility with over 500 employees, serving more than 60 international pharmaceutical companies. SPL offers full-service CDMO capabilities from development to production and registration across a wide range of dosage forms including tablets, capsules, powders, oral liquids, creams, suppositories, ovules, and softgel capsules.

Srikem Laboratories Pvt Ltd

India

Srikem Laboratories Pvt Ltd is an Indian pharmaceutical company based in Navi Mumbai (MIDC Taloja industrial area) that manufactures active pharmaceutical ingredients. Search results indicate they supply APIs including Clotrimazole and antibacterials for systemic use. No website text was available. They are listed on PharmaSource and appear in a Global Business Reports feature on India Pharmaceuticals as investing in R&D and manufacturing capabilities. Limited information prevents a more detailed classification, but evidence points to API manufacturing rather than contract drug product manufacturing.

Sunsho Pharmaceutical Co., Ltd.

Japan

Sunsho Pharmaceutical Co., Ltd. is Japan's leading contract manufacturing pharmaceutical company, operating as a CDMO across three business verticals: health food (supplements), new applications (flavor capsules), and pharmaceuticals (generic drugs). The company specializes in capsule and formulation technologies, with the Nanryo Factory being one of the largest soft capsule manufacturing plants in Japan.

Swiss Garnier Life Sciences

India

Swiss Garnier Life Sciences is an Indian contract manufacturing organization operating multiple pharmaceutical manufacturing plants. The company produces tablets (coated and uncoated), capsules, sachets, liquids, and ointments across four manufacturing facilities. Plant 1 (Mehatpur, Himachal Pradesh) handles pharmaceutical products with 1,680 million units capacity, while Plant 2 focuses on nutraceutical and Ayush products with 2,520 million units capacity. The company achieved DIGEMID Peru certification with zero observations in September 2025.

Swiss Parenterals Limited

India

Swiss Parenterals Limited is an Indian pharmaceutical manufacturing company producing tablets, capsules, injections, and sterile eye preparations. The company has integrated with Eris Lifesciences Limited and operates as a CDMO/CMO partner. The company manufactures across a wide range of dosage forms and technologies, including parenteral drug products and oral solid dosage forms.

Synokem Pharmaceuticals Ltd

India

Synokem Pharmaceuticals Ltd is one of India's largest CDMOs, backed by TA Associates investment (2023). The company specializes in contract development and manufacturing, ethical marketing, and pharmaceutical exports. Synokem acquired Nitin Lifesciences Ltd and Parabolic Drugs Ltd to expand API production capacity. The company recently launched a modernized cephalosporin injectable manufacturing block for commercial production. Synokem's website is currently suspended but the company remains operational and expanding.

Tedor Pharma Inc

United States

Tedor Pharma is a US-based CDMO with 20+ years of experience specializing in solid oral dosage forms. Located in Cumberland, Rhode Island, they provide end-to-end outsourcing from IND/NDA/ANDA through commercial manufacture. Services include formulation development, clinical trial manufacturing (including placebo), commercial GMP manufacturing at various scales, analytical services (characterization, testing, development, QA), and clinical supply chain management. FDA-registered and inspected (5 inspections, all VAI), DEA-licensed for controlled substances Schedules II-V. They have 2 FDA-approved products (tablets, oral route). The company announced a recapitalization and new management.

Tekro Lab

Czechia

Czech pharmaceutical CRO and CDMO specializing in veterinary pharmaceuticals and animal health. Offers GMP-certified contract manufacturing of solid dosage forms (premixes, pellets, tablets) with various active substances including penicillins, tetracyclines, and potentiated sulphonamides. Also provides contract research (preclinical studies), pharmacovigilance services, and regulatory affairs for veterinary medicinal products. Over 30 years of experience in the pharma industry.

Thompson & Capper Ltd (HBI Thompson & Capper)

United Kingdom

UK-based contract manufacturer specializing in nutritional supplements and pharmaceutical tablets. Part of HBI (Healthy Business International) group, now joined Ourvita Group. Tailor-makes vitamins, minerals, health supplements, and specialty tablets. Offers a wide range of dosage formats including tablets, chewies, melts, effervescents, powders, hard gel capsules, soft gel capsules, and liquids. Handles 4,000+ raw materials. FDA-registered. Focused on nutritional and supplement contract manufacturing rather than prescription pharmaceutical manufacturing.

Titan Laboratories Pvt Ltd

India

Titan Laboratories Pvt Ltd is an integrated Indian pharmaceutical company and the first Indian pellet company to receive EU-GMP Written Confirmation. Established in 2004, it manufactures and exports pharmaceuticals and APIs across 47 countries, with specialization in pellets, granules, tablets, capsules, and creams/ointments. The company holds EU-GMP, TGA, ANVISA, WHO-GMP, MFDS, and other international approvals.

Tosca Pharmachem (Tosco Pharmachem Pvt Ltd)

India

Tosco Pharmachem Pvt Ltd is an Indian pharmaceutical contract manufacturing company providing third-party/contract manufacturing services for formulated pharmaceutical products. The company's website has been compromised by spam, but search results confirm it operates as a CMO offering pharmaceutical manufacturing across multiple dosage forms including tablets, capsules, liquids, and topicals.

Trident Lifeline Limited

India

Trident Lifeline Limited is an Indian pharmaceutical company established in 2014, engaged in manufacturing and marketing finished dosage forms. The company offers contract manufacturing services (hybrid model: own products + third-party manufacturing) for tablets, capsules, dry powder, liquid, ointment, gel, and injectable products. WHO-GMP compliant with global presence in 40+ countries. 3133+ products registered with India FDA, 989+ globally registered products.

Valpharma Group

San Marino

Valpharma Group is a pharmaceutical and nutraceutical CDMO based in San Marino with 40+ years of experience. The group consists of Valpharma San Marino S.p.A. and Valpharma International S.p.A. (two CDMO pharmaceutical companies) plus Erba Vita Group S.p.A. (nutraceuticals). They specialize in modified-release products in capsules and tablets, including narcotic and psychotropic substances. Services include contract manufacturing, tech transfer, regulatory and e-CTD management, pharmaceutical development, stability studies, and IMP (investigational medicinal product) batch production. They operate three production plants and are routinely audited by Italian Health Authorities for GMP compliance. Products sold in 70+ countries.

Vefa İlaç San. ve Tic. A.Ş.

Turkey

Vefa Ilac San. ve Tic. A.S. is a Turkish pharmaceutical manufacturer based in Beylikduzu, Istanbul, established in 2012 with GMP certification obtained in 2013. They manufacture pharmaceuticals, traditional herbal medicines, food supplements, and personal care products for both domestic and export markets. They have significant production capacity: 902 million tablets/year, 270 million capsules/year, 252 million coated units/year, 48 million bottles/year, and 15 million cream & gel units/year. Products are exported to Azerbaijan, Georgia, Ukraine, Iraq, Yemen, Saudi Arabia, and Romania. They hold WHO GMP and ISO 9001:2015 certifications. Their vision focuses on becoming a leading private label (contract) production base in Eurasia for pharmaceutical and nutraceutical products.

Vianex S.A.

Greece

Vianex S.A. is a prominent Greek pharmaceutical company listed on PharmaSource as a CDMO. The company is described as specializing in contract development and manufacturing. While the website content is primarily in Greek and could not be fully parsed, PharmaSource confirms CDMO services. The company appears to have multiple manufacturing facilities (Factory A, B, C, D mentioned in navigation) and covers a broad range of dosage forms. Founded by Paul J. Giannacopoulos.

West Coast Pharmaceutical Works Ltd

India

West Coast Pharmaceutical Works Ltd is an Indian manufacturer of pharmaceutical formulations primarily for human and veterinary use. The company also produces nutraceutical products. West Coast is FDA-registered and operates contract manufacturing services for pharmaceutical formulations.

Wiewelhove

Germany

Wiewelhove GmbH is a German contract manufacturer specializing exclusively in solid dosage forms. The company provides galenic development, wet granulation, compaction, blending, tabletting, capsule filling, film coating, sugar coating, bottling, blistering, and packaging services. Wiewelhove positions itself as a reliable partner for all aspects of contract manufacturing of solid dosage forms.

Xedev

Belgium

Xedev is a flexible CDMO based in Belgium, specialized in formulation and process development for oral solid dosage forms. They offer early-phase development services including spray drying, hot melt extrusion, amorphous solid dispersions, and GMP clinical manufacturing for Phase I and Phase II batches.

YSK Laboratories Pvt Ltd

India

YSK Laboratories Pvt Ltd is an Indian pharmaceutical company specializing in 'SMART APIs' -- semi-formulated Active Pharmaceutical Ingredients in Directly Compressible (DC) Granule form. These granules can be directly compressed into tablets in a single step, eliminating granulation. Annual production capacity of 400-500 metric tons of DC Granules.

Zile Bonbons (Zile Ltd.)

Switzerland

Zile Bonbons AG is a Swiss specialist contract manufacturer of lozenges, chews, and dragees for the pharmaceutical (OTC), nutraceutical, dietary supplement, and confectionery industries. Headquartered in Rupperswil, Switzerland, they have a dedicated OTC lozenges manufacturing plant. They provide full-service contract development and manufacturing from product conception through commercial production, including formulation development, prototyping, sourcing, manufacture, packaging, and logistics. Their technologies include stamping, cutting, moulding, and coating, with primary packaging options (wrapper/flow pack, bags, flip-top boxes, bars, blisters). They manufacture alternative drug delivery systems as centre-filled OTC lozenges with precise API dosage. They have pharmaceutical GMP expertise and are FDA-registered (FEI 3003236010) with 1 FDA inspection (VAI). Classified as CMO rather than CDMO because their development work is focused on lozenge formulation for third parties, but they do not position themselves as offering full drug development services beyond the lozenge/chew format.

ABC Farmaceutici, an ICE Pharma company, is an Italian CDMO established in 1925 specializing in oral solid and liquid formulation manufacturing. Their 76,000 sqm facility in Ivrea (near Turin) is fully GMP certified and regularly inspected by AIFA and FDA. As part of ICE Pharma, they manage the entire drug supply chain from API through finished dosage form manufacturing.

Contract Packaging Resources is a member of the Aenova Group, a worldwide leading CDMO for the pharmaceutical and healthcare industry. The Aenova Group provides comprehensive pharmaceutical manufacturing including solid dosage forms, sterile fill and finish, semi-solids, non-sterile liquids, softgels, gummies, and packaging services. The Latina site in Italy serves as the central sterile manufacturing facility with capacity for over 100 million units per year, handling biologics including monoclonal antibodies, peptides, and vaccines with isolator technology.

Anhui Biochem Pharmaceutical (ABUP) is a Chinese pharmaceutical company manufacturing APIs, intermediates, and finished dosage forms, with a focus on antiviral drugs (AIDS and hepatitis) and Parkinson's disease medications. They also offer customized processing (contract manufacturing) services.

Bacthera was a specialized CDMO focused on live biotherapeutic products (LBPs) and microbiome-based therapeutics, operating as a joint venture that originated from Lonza and Chr. Hansen. The company provided development and cGMP manufacturing services across the live biotherapeutics value chain, from drug substance production through drug product manufacturing. Bacthera collaborated with Seres Therapeutics for commercial manufacturing of SER-109 (a treatment for recurrent C. difficile infection), acquired a cGMP site in Leon, Spain, and received regulatory approvals from Swissmedic and the Danish Medicines Agency. However, Bacthera ceased its CDMO operations by September 2025, with its equipment subsequently acquired by EXPERT'Biome (Lallemand's CDMO division). Note: this company has closed its CDMO operations.

BioReliance (Merck KGaA, MilliporeSigma)

Scotland

BioReliance is the contract testing services division of Merck KGaA (MilliporeSigma), providing GMP-compliant biosafety testing, product characterization, and quality control testing for biologics, vaccines, and cell/gene therapies. With 25 FDA-registered FEI numbers and 102 FDA inspections across global sites, they are one of the largest contract testing organizations. They provide end-to-end testing solutions but do NOT manufacture drug substances or drug products -- they are a testing CRO.

Bushu Pharma is Japan's premier CDMO with over 25 years of experience, specializing in contract manufacturing of solid dosage formulations, sterile injectables, lyophilized products, and prefilled syringes for both clinical trial supplies and commercial products. The company operates five factories in Japan with GMP certifications from 56 countries including FDA, EMA, and PMDA, serving over 90 pharmaceutical companies globally with nearly 50% of sales from foreign-affiliated clients.

Caplin Point Laboratories is a fully integrated Indian pharmaceutical company with a dominant presence in Latin America and Francophone Africa, and a growing presence in the US and EU. Through its subsidiary Caplin Steriles, the company manufactures sterile injectables, ophthalmic products, pre-mix bags, and pre-filled syringes, with 46 FDA-approved products.

Cardinal Health Clinical Supply Services is a division of Cardinal Health providing contract manufacturing and pharmacy solutions for biopharmaceutical companies. The company offers clinical supply services, sterile injectable manufacturing, and radiopharmaceutical contract manufacturing, with 39 FDA-registered facilities and extensive commercial-scale production capabilities.

Cenra Pharma (formerly CCPC, China Chemical & Pharmaceutical Co.) is a Taiwanese pharmaceutical company established in 1952 that develops and manufactures APIs and generic drugs, also providing CMO/CDMO services. The company has FDA and PMDA facility approvals, PIC/S GMP compliance, and offers services from API selection through formulation development and commercial manufacturing. Cenra specializes in high-potency drugs including immunosuppressants and oncology drugs, with dedicated production lines for penicillins, cephalosporins, carbapenems, and immunosuppressants.

China Resources Zizhu Pharmaceutical Co., Ltd. (CRZP), founded in 1969, is a high-tech pharmaceutical enterprise and subsidiary of China Resources Pharmaceutical. The company manufactures APIs and finished dosage forms including tablets, oral liquids, and topicals, with FDA registration and 5 FDA inspections on record, and 2 FDA-approved products.

CordenPharma is a full-service CDMO providing integrated development and manufacturing of APIs, drug products, and lipid excipients across a global network of cGMP facilities in Europe and North America. The company offers capabilities spanning peptides, oligonucleotides, highly potent and oncology compounds, small molecules, injectables, lipid nanoparticles (LNPs), and oral solid dosage forms. CordenPharma is investing over EUR 500M in a new peptide manufacturing facility in Muttenz, Switzerland, and expanding its Colorado site for large-scale peptide production.

Corealis Pharma Inc. is the same entity as Corealis Pharma, a privately held GMP-compliant CDMO based in Laval, Quebec, Canada. The company specializes in oral solid dosage forms, providing formulation development and cGMP clinical supply manufacturing for Phase I through early Phase III trials. Corealis has expanded its facilities in Laval's Biotech City with an investment of over $10 million and partners with Rottendorf Pharma and Bora Pharmaceuticals for integrated development-to-commercial services.

Fermion, a wholly owned subsidiary of Orion Corporation (Finland), is a CDMO specializing in developing, manufacturing, and marketing small molecule Active Pharmaceutical Ingredients (APIs), including HPAPIs, cytotoxics, steroids, generics, and controlled substances. Together with its parent Orion, it offers integrated contract development and manufacturing services for both drug substances and drug products, covering the full lifecycle from preclinical to commercial scale. FDA-approved since 1979 and EMA-approved since 1971.

Huazhong Pharmaceutical Co., Ltd. (HPC) is a Chinese pharmaceutical company established in 1995, manufacturing APIs, intermediates, and finished dosage forms including tablets. The company has GMP manufacturing sites with capabilities in both biological transformations and chemical synthesis, producing products such as albendazole, isoniazid, paracetamol, and nifedipine tablets.

ICE Pharma is a niche API and specialty ingredients CDMO founded in 1949 in Italy, focused on the development and manufacture of bile acid derivatives including Ursodeoxycholic Acid (UDCA). The company operates a fully vertically integrated manufacturing network of 7 global production facilities and provides CDMO services for both APIs and finished dosage forms, as well as custom carbohydrate chemistry through its Dextra unit.

IDI Integratori Dietetici Italiani srl is an Italian pharmaceutical company engaged in the development and manufacturing of pharmaceutical products, dietary supplements, and medical devices. The company has FDA-registered facilities and produces a range of products including tablets, creams, oral solutions, and injectable formulations across multiple therapeutic areas.

ICE Pharma (Industria Chimica Emiliana) is an Italian integrated pharmaceutical company with over 70 years of experience and 1,500 employees worldwide. The company is a leading global producer of Ursodeoxycholic acid (UDCA) and bile acid derivatives, offering CDMO services for solid and liquid finished dosage forms and complex carbohydrates. ICE Pharma operates 7 manufacturing facilities across North and South America, Europe, Asia, and Oceania.

International Drug Development Institute(IDDI)

Belgium

IDDI (International Drug Development Institute) is a clinical data science CRO specializing in biostatistics, clinical data management, strategic consulting, and eClinical technologies. Founded in 1991, the company has completed over 1,500 clinical trials for 350+ clients, with 80% repeat business. IDDI's therapeutic focus is oncology and ophthalmology, representing 75% of their work.

JEWIM Pharmaceutical (Shandong) Co., Ltd. is a Chinese pharmaceutical company in transformation, focusing on innovative drugs and complex drug delivery systems including inhalation products, nasal sprays, and long-acting injectable microspheres. The company is an established CDMO/CMO partner for multinational pharma companies including Johnson & Johnson (Xian Janssen), Kenvue, and Bayer, with quality systems certified by US FDA and Australian TGA. Products are exported to over 80 countries.

Jubilant HollisterStier CMO

Canada

Jubilant HollisterStier CMO (subsidiary of Jubilant Pharma) specializes in sterile fill-finish, lyophilization, injectables, ophthalmics, otics, topicals, and liquids for pharmaceutical and biopharmaceutical clients. End-to-end services from process development to inspection and packaging. Facilities in Spokane, WA and Montreal, QC. Won AWB Manufacturer of the Year 2024 and Manufacturing Excellence Award 2025. Largest manufacturer by employees in Spokane area. 92% repeat customer rate. FDA registered with 4 FEI numbers, 28 inspections (6 NAI, 18 VAI, 4 OAI -- elevated regulatory risk).

Lupin Limited (Lupin Manufacturing Solutions)

Brazil

Lupin Manufacturing Solutions (LMS) is the CDMO arm of Lupin Limited, one of India's largest pharmaceutical companies. LMS offers integrated CDMO services spanning API manufacturing, formulation development, and finished dosage form production. They operate 16 FDA-registered facilities with 512 FDA-approved products. They have recently expanded into oncology with a dedicated block at Vizag, India, and formed a strategic alliance with PolyPeptide for peptide supply chain scaling. Their extensive regulatory track record includes FDA, WHO, and multiple international approvals.

Northeast Pharmaceutical Group (NEPG) is a large-scale comprehensive pharmaceutical enterprise in Shenyang, China, under Fangda Group. The company operates three major business segments: chemical synthetic API and bio-fermentation API, western medicinal preparations and micro-ecological preparations, and medical business distribution. NEPG is China's first Vitamin C producer and the inventor of the two-step fermentation technology for VC production, with the world's largest Piracetam production capacity.

Norwich Pharmaceuticals (now Norwich Pharma Services, part of Alvogen) is a US-based contract development and manufacturing organization with over 130 years of pharmaceutical manufacturing history in Norwich, New York. The company manufactures generic medications including capsules, tablets, and extended-release tablets. Norwich is FDA-registered with operations including analysis, labeling, manufacturing, packing, relabeling, and repacking, and has 3 FDA-approved products with strong inspection history (6 NAI out of 7).